Clinical Trials Worldwide
- Entry
- Reader's Guide
- Entries A-Z
- Subject Index
-
FOUR PIONEERING STUDIES in neurological disorders include a phase 1 study at the University of Texas Health Science Center at Houston that is evaluating the safety of autologous (using the patient's own cells) bone marrow treatments in 10 children aged 5–14 years with traumatic brain injury; a phase 1/2 study at the University of Cambridge to determine the safety and effectiveness of bone marrow—derived autologous mesenchymal stem cells in multiple sclerosis; a phase 1 safety study on the use of autologous bone marrow stem cells for acute stroke, sponsored by the Federal University of Rio de Janeiro in Brazil; and a recently completed phase 1 evaluation at Inha University in Incheon, Korea, where autologous bone marrow stem cells were used to treat acute and chronic ...
-
-
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- R
- S
- T
- U
- V
- W
- Y
-
167050- Loading...
Also from SAGE Publishing
- CQ Library American political resources opens in new tab
- Data Planet A universe of data opens in new tab
- Lean Library Increase the visibility of your library opens in new tab
- SAGE Journals World-class research journals opens in new tab
- SAGE Research Methods The ultimate methods library opens in new tab
- SAGE Stats Data on demand opens in new tab